Form 4 Filing for Anixa Biosciences Inc.

This filing details a transaction by Amit Kumar, Chief Executive Officer and Director of Anixa Biosciences Inc. On July 31, 2026, Mr. Kumar acquired 5,000 shares of the company's Common Stock at a price of $3.47 per share. Following this transaction, Mr. Kumar directly owns 657,000 shares of Anixa Biosciences Inc. Common Stock. The transaction was reported on Form 4 and deemed to be an acquisition.